DERMATOLOGY CLINIC BUSINESS PLAN

I. Executive Summary

Company Description

DermWell Clinic—named for dermatology and whole-person wellness—launches in 2026 as a full-service dermatology practice in a high-growth U.S. market. We operate in the outpatient medical and cosmetic dermatology sector, offering medical dermatology, surgical procedures, laser and energy-based treatments, injectables, and licensed aesthetic services. The team includes board-certified dermatologists, physician assistants, and licensed aestheticians. One-liner: We combine medical necessity and aesthetic desire under one roof.

We deliver care through a streamlined operational model that maximizes patient throughput without sacrificing clinical quality: standardized intake, protocol-driven procedures, same-day minor surgery capacity, and an integrated follow-up program. What sets us apart is a clinical-first aesthetics model, outcome-tracking, and a modern patient experience that shortens lead times and increases retention. Target customers are adults 25–65 with disposable income and insurance coverage, and referral sources include primary care and plastic surgery. Short-term goal: reach 6,000 visits and break even by month 18. Long-term goal: scale to three regional locations and sustain 60% gross margin on aesthetic services within five years.

Problem

Millions of Americans live with chronic skin, hair, and nail conditions and often wait several months for specialist appointments, creating long diagnostic delays, reduced treatment adherence, and lower patient satisfaction. The current market prioritizes volume over individualized care, rarely combines medical screenings with high-end cosmetic services in one location, and lets administrative bottlenecks push back preventative skin cancer screenings—leading to missed early detections and poorer clinical outcomes.

One-liner: delayed, impersonal care worsens clinical outcomes and patient well-being.

Solution

The clinic addresses long dermatology wait times, fragmented care, and outdated processes by offering integrated medical and cosmetic services in a single modern practice. It delivers comprehensive medical dermatology (skin cancer screening, acne, psoriasis, eczema) and evidence-based cosmetic procedures (Botox, fillers, lasers, peels) with licensed clinicians, protocolized treatment plans, documented consent, and measurable follow-up to restore health and confidence.

One line: comprehensive medical dermatology and evidence-based cosmetic care delivered in a modern, protocol-driven clinic that links treatment to measurable results.

Mission Statement

Our mission is to deliver patient-centered dermatological care through operational innovation and clinical expertise. We help every patient achieve healthy, vibrant skin by providing timely access to medical and cosmetic solutions while reducing barriers to specialist care and enhancing community well-being. Through efficiency and empathy we set a new standard for modern dermatology practice and empower patients with confidence in expert skin health management.

Key Success Factors

These five factors will determine our ability to reach the 2026–2030 targets and sustain profitable growth.

• Scale practitioner utilization from 60.0% to 90.0% to achieve target revenues and margin.
• Attract and retain top-tier medical talent with competitive compensation and a modern work environment.
• Maintain a 7-month payback period and 26% IRR to ensure financial sustainability and fund expansion.
• Execute the $580,000 advanced-technology investment to differentiate services and improve throughput.
• Build a robust referral network and strong digital presence to drive the patient volume needed for 2026–2030.

Financial Summary

Financial performance is strong: rapid breakeven in Jan-26 and materially positive EBITDA from year one.

Financial requirements: minimum cash $721,000 (needed by Feb-26); payback in 7 months; breakeven Jan-26. Anticipated investor return: ROE 31.45% (IRR 0.26%).

Overall outlook: high-margin, fast-payback investment with strong early EBITDA growth.

Funding Requirements

The clinic requires USD 1,301,000 to launch in 2026; this covers USD 580,000 in capital expenditures and USD 721,000 in working capital, targets a 26% IRR, achieves breakeven in month one, and delivers Year 1 EBITDA of USD 1,548,000.